We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
CINCINNATI — With September’s deadline for displaying unique device identifiers on high-risk devices just around the corner, rollout for many manufacturers is well underway. Read More
A rise in whistleblower lawsuits involving off-label marketing of medical devices has sparked increased scrutiny by the FDA, and the suits are not likely to stop anytime soon, experts say. Read More
CINCINNATI — The FDA’s increasing emphasis on human factors testing is creating new momentum for labeling research, an industry consultant told conference-goers at the FDA/Xavier University MedCon conference. Read More